Know Labs approved for glucose monitoring clinical trial

2022 02 04 16 47 2908 Sugar Drinks 400

Know Labs recently received approval from an independent institutional review board (IRB) for the protocol of its upcoming internal clinical trial featuring its Bio-RFID prototype.

The trial will see blood glucose readings taken every five minutes for participants through a fingerstick device over a period of three to five hours. Participants will drink a glucola drink with 75 g of sugar, which should change their respective blood glucose levels. The Bio-RFID prototype will then measure these changes.

The company said the IRB approval brings it one step closer to a presubmission meeting with the U.S. Food and Drug Administration, and eventual launch of a commercial blood glucose monitoring product.

Page 1 of 15
Next Page